Cutler Group LLC / CA - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 1 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$1
-99.9%
10,6000.0%0.00%
Q3 2022$1,000
-50.0%
10,6000.0%0.00%
Q2 2022$2,000
-60.0%
10,6000.0%0.00%
Q1 2022$5,000
-16.7%
10,6000.0%0.00%
Q4 2021$6,000
-40.0%
10,6000.0%0.00%
Q3 2021$10,000
-47.4%
10,6000.0%0.00%
-100.0%
Q2 2021$19,000
-5.0%
10,600
-1.9%
0.00%0.0%
Q1 2021$20,000
+53.8%
10,800
-7.7%
0.00%0.0%
Q4 2020$13,000
-69.0%
11,700
-66.3%
0.00%
-66.7%
Q3 2020$42,000
+366.7%
34,700
+71.2%
0.00%
+200.0%
Q4 2018$9,000
-75.0%
20,265
-29.7%
0.00%
-50.0%
Q3 2018$36,000
+9.1%
28,817
+289.4%
0.00%
-33.3%
Q1 2018$33,000
-62.5%
7,400
-48.4%
0.00%
-25.0%
Q4 2017$88,000
+417.6%
14,354
-77.3%
0.00%
Q3 2017$17,000
-82.3%
63,297
-45.5%
0.00%
-100.0%
Q2 2017$96,000
-48.4%
116,056
-49.2%
0.00%
-50.0%
Q1 2017$186,000
+24.0%
228,456
+138.3%
0.01%
+33.3%
Q4 2016$150,000
+2400.0%
95,856
+4464.6%
0.01%
Q3 2016$6,0002,1000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$6,307,0004.30%
ETF MANAGERS GROUP, LLC 8,103,641$10,130,0000.22%
AdvisorShares Investments LLC 271,873$340,0000.08%
Platform Technology Partners 60,000$75,0000.04%
PINNACLE ASSOCIATES LTD 942,079$1,178,0000.02%
HRT FINANCIAL LP 883,510$1,104,0000.02%
Virtu Financial LLC 153,908$192,0000.02%
Tekla Capital Management LLC 413,481$517,0000.02%
Aries Wealth Management 23,400$33,0000.02%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 56,932$71,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders